Cart
sales@molnova.com
6,12,15-Trihydroxy-5,8,11,13-abietetra-7-one
CAS No. 371155-09-8
6,12,15-Trihydroxy-5,8,11,13-abietetra-7-one( ——— )
Catalog No. M39274 CAS No. 371155-09-8
6,12,15-Trihydroxy-5,8,11,13-abietetra-7-one
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 5MG | 611 | In Stock |
|
| 25MG | Get Quote | In Stock |
|
| 50MG | Get Quote | In Stock |
|
| 100MG | Get Quote | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product Name6,12,15-Trihydroxy-5,8,11,13-abietetra-7-one
-
NoteResearch use only, not for human use.
-
Brief Description6,12,15-Trihydroxy-5,8,11,13-abietetra-7-one
-
Description6,12,15-Trihydroxy-5,8,11,13-abietetra-7-one
-
In Vitro———
-
In Vivo———
-
Synonyms———
-
PathwayOthers
-
TargetOther Targets
-
Recptor———
-
Research Area———
-
Indication———
Chemical Information
-
CAS Number371155-09-8
-
Formula Weight330.4
-
Molecular FormulaC20H26O4
-
Purity>98% (HPLC)
-
Solubility———
-
SMILES———
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
molnova catalog
related products
-
Orexin A (human, rat...
Endogenous agonist at orexin receptors (Ki values are 20 and 38 nM for OX1 and OX2 receptors respectively). Stimulates feeding following central administration and may be involved in the control of sleep-wake cycle and other hypothalamic functions.
-
L-4FPG
L-4FPG inhibits the neutral amino acid transporters ASCT1 and ASCT2. It also shows good brain penetration and potently reduces amphetamine-induced hyperlocomotion.
-
3-[2-(3,4,5-trimetho...
3-[2-(3,4,5-trimethoxyphenyl)ethyl]phenol
